Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Dongyi Tony Du"'
Autor:
Michael V. Murphy, Robert L. Davis, Michael Klompas, Cynthia Nakasato, Mayur Ramesh, Wei Hua, Michael Schum, Craig Zinderman, Thomas A. DeCoster, Laura Johnson, Melissa G. Butler, James D. Nordin, Karoll J. Cortez, Ann Von Worley, Richard Platt, Lingling Li, Dongyi Tony Du
Publikováno v:
Infection Control & Hospital Epidemiology. 37:827-833
OBJECTIVETo determine the effect of graft choice (allograft, bone-patellar tendon-bone autograft, or hamstring autograft) on deep tissue infections following anterior cruciate ligament (ACL) reconstructions.DESIGNRetrospective cohort study.SETTING AN
Autor:
John Laschinger, Nilsa Loyo-Berrios, Rob Warnock, Dongyi Tony Du, Stephen McKean, Xiaoxiao Lu, Danica Marinac-Dabic
Publikováno v:
The Journal of thoracic and cardiovascular surgery.
Both biological and mechanical prosthetic valves are treatment choices for aortic valve replacement. We aimed to characterize the selection of prosthetic aortic valves among elderly Medicare patients.This was a retrospective analysis of patients aged
Autor:
Chris Worrall, Richard A. Forshee, Hector S. Izurieta, Samuel B Barone, Craig E. Zinderman, Thomas E. MaCurdy, Jeffrey A. Kelman, Austin Wagoner, Dongyi Tony Du
Publikováno v:
Ophthalmology. 121:290-298
Objective To estimate the incidence of infectious endophthalmitis after corneal transplant or cataract surgery, to evaluate the trend of endophthalmitis during the study period, and to assess demographic risk factors for endophthalmitis after surgeri
Publikováno v:
Medical Care. 50:987-992
The Food and Drug Administration (FDA) issued a Public Health Advisory entitled "Suicidal Thinking in Children and Adolescents Being Treated with Strattera (Atomoxetine)" on September 29, 2005. At FDA's request, the manufacturer subsequently added a
Publikováno v:
Journal of the American Geriatrics Society. 58:944-949
OBJECTIVES: To empirically estimate changes of potentially inappropriate medication (PIM) use attributable to the Medicare Part D prescription drug benefit. DESIGN: Difference-in-difference strategy in the quasi-experimental design with a control gro
Autor:
Mayur Ramesh, Wei Hua, Cynthia Nakasato, Craig Zinderman, James D. Nordin, Michael Schum, Karoll J. Cortez, Melissa G. Butler, Michael Klompas, Michael V. Murphy, Ann Von Worley, Richard Platt, Laura Johnson, Thomas A. DeCoster, Robert L. Davis, Dongyi Tony Du, Lingling Li
Publikováno v:
Infection control and hospital epidemiology. 35(6)
Objective.To explore the feasibility of identifying anterior cruciate ligament (ACL) allograft implantations and infections using claims.Design.Retrospective cohort study.Methods.We identified ACL reconstructions using procedure codes at 6 health pla
Publikováno v:
Health affairs (Project Hope). 31(5)
In 2007 the federal government began requiring drug makers to include in their print direct-to-consumer advertisements information for consumers on how to contact the Food and Drug Administration directly, either by phone or through the agency's webs
Publikováno v:
Journal of the American Geriatrics Society. 58(5)
To empirically estimate changes of potentially inappropriate medication (PIM) use attributable to the Medicare Part D prescription drug benefit.Difference-in-difference strategy in the quasi-experimental design with a control group.U.S. nationally re
Autor:
Dongyi Tony Du, Hector S. Izurieta, Chris Worrall, Thomas E. MaCurdy, William E. Encinosa, Christopher K. Johnson, Rob Warnock, Stephen McKean, John Laschinger, Jeffrey A. Kelman, Art Sedrakyan
Publikováno v:
JAMA Internal Medicine. 174:1788
Early mortality for patients who undergo aortic valve replacement (AVR) may differ between mechanical and biological prosthetic (hereinafter referred to as bioprosthetic) valves. Clinical trials may have difficulty addressing this issue owing to limi